PODD
US EQUITY
Health Care
Health Care Equipment
CIK: 1145197
Insulet Corporation (PODD) Quant Factor Diagnostic & Fair Value Model
Insulet Corporation (Ticker: PODD) is listed in the Health Care sector (Health Care Equipment). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.
$149.01
+0.60%
Latest Close (2026-10-23)
Market Cap: $10.33B
P/E Ratio: 27.2
Momentum Strength
3M / 12M
-9.69%
1M: +9.74%
12M: -54.74%
Quality (ROE)
Point-in-Time
+26.72%
Trailing Return on Equity
Technical Trend
RSI 14
73.0
SMA50: $140.50
SMA200: $182.16
Valuation Multiplier
Trailing
27.2
Moderate Valuation Corridor (15x - 30x P/E)
📊
Valuation & Multi-Factor Diagnostic
Moderate Valuation Corridor (15x - 30x P/E)
PODD trades within a typical sector multiple band (27.2x P/E), broadly aligned with trailing earnings.
⚡
Benchmark Factor Strategy
S&P 500 Momentum Alpha Strategy
This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.
📈 Daily Candlestick & Volume Quant Chart
Interactive lightweight price action & volume breakdown over recent 90 trading days.
均线整理 (MA20/50)
Piotroski F-Score: 6/9 (Moderate Financial Health)
Official Point-in-Time Financial Filing History
Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.
备案 CIK: 1145197 · 10-K 年报 / 10-Q 季报
| Form | Period End | Filing Timestamp (Point-in-Time) | Revenue | Net Income | Operating CF | EPS (Diluted) |
|---|---|---|---|---|---|---|
| 10-Q | 2026-06-30 | 2026-08-05 | $801.70M | $95.00M | $202.20M | $1.37 |
| 10-Q | 2025-12-31 | 2026-08-05 | - | - | - | - |
| 10-Q | 2025-06-30 | 2026-08-05 | $649.10M | $22.50M | $260.30M | $0.32 |
| 10-Q | 2026-03-31 | 2026-05-06 | $761.70M | $91.10M | $113.80M | $1.30 |
| 10-Q | 2025-03-31 | 2026-05-06 | $569.00M | $35.40M | $63.80M | $0.50 |
| 10-K | 2025-12-31 | 2026-02-18 | $2.71B | $247.10M | $569.30M | $3.48 |
| 10-K | 2024-12-31 | 2026-02-18 | $2.07B | $418.30M | $430.20M | $5.78 |
| 10-K | 2023-12-31 | 2026-02-18 | $1.70B | $206.30M | $145.70M | $2.94 |
💡 Methodology & Frequently Asked Questions
Key reference details regarding Insulet Corporation (PODD) valuation multiples, momentum factors, and point-in-time filing conventions.
How should PODD's current valuation multiple be interpreted? ↓
PODD trades at a trailing P/E of 27.2x within the Health Care sector (moderate valuation corridor (15x - 30x p/e)). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.
What are PODD's key momentum and technical factor indicators? ↓
As of the latest close, PODD shows a 1-month return of +9.74%, 3-month return of -9.69%, and 12-month return of -54.74%, with a 14-day RSI of 73.0. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.
What is Point-in-Time (PIT) financial data and why does it matter for PODD? ↓
Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.
How can PODD be incorporated into systematic factor models? ↓
PODD can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.